N-Fmoc-N-(2,2,2-trifluoroethyl)glycine incorporates a trifluoroethyl group that modifies polarity and electronic character. The residue is applied to examine fluorine-driven interactions and altered hydrogen-bonding patterns. Researchers employ it in designing peptides with unique conformational profiles. Its protected form aids controlled synthesis.
CAT No: R2135
CAS No:1486953-68-7
Synonyms/Alias:1486953-68-7;N-Fmoc-N-(2,2,2-trifluoroethyl)glycine;2-{[(9H-fluoren-9-ylmethoxy)carbonyl](2,2,2-trifluoroethyl)amino}acetic acid;2-[9H-fluoren-9-ylmethoxycarbonyl(2,2,2-trifluoroethyl)amino]acetic acid;2-({[(9h-fluoren-9-yl)methoxy]carbonyl}(2,2,2-trifluoroethyl)amino)acetic acid;{[(9H-fluoren-9-ylmethoxy)carbonyl](2,2,2-trifluoroethyl)amino}acetic acid;LJC95368;AKOS017496559;EN300-81360;F80622;N-(((9H-FLUOREN-9-YL)METHOXY)CARBONYL)-N-(2,2,2-TRIFLUOROETHYL)GLYCINE;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More